---
document_datetime: 2023-09-21 18:59:06
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/intrinsa-epar-all-authorised-presentations_en.pdf
document_name: intrinsa-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8450785
conversion_datetime: 2025-12-20 17:59:08.949466
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number       | Invented   | Strength                | Pharmaceutical    | Route of        | Packaging                                                   | Package size           |
|-----------------|------------|-------------------------|-------------------|-----------------|-------------------------------------------------------------|------------------------|
| EU/1/06/352/001 | Intrinsa   | 300 micrograms/24 hours | Transdermal patch | Transdermal use | sachet (paper/LDPE/Alu/ethylene methacrylic acid copolymer) | 2 transdermal patches  |
| EU/1/06/352/002 | Intrinsa   | 300 micrograms/24 hours | Transdermal patch | Transdermal use | sachet (paper/LDPE/Alu/ethylene methacrylic acid copolymer) | 8 transdermal patches  |
| EU/1/06/352/003 | Intrinsa   | 300 micrograms/24 hours | Transdermal patch | Transdermal use | sachet (paper/LDPE/Alu/ethylene methacrylic acid copolymer) | 24 transdermal patches |

Medicinal product no longer authorised